Biobanking Market Report 2023-2028 Industry Trends, Share, Size, Demand and Futu

1. Biobanking Market Report 2023 By Specimen type, Biobank Type, Application and End User Key Regions and Competitive Landscape www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. industrial, and high technology IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Biobanking Market Outlook 2023-2028: The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028. Biobanking involves collecting and preserving human biospecimens for future use in research, diagnosis, and biodiversity studies. These samples are stored for numerous years and used by researchers in cross-purpose research studies to understand health and various diseases better. In recent years, biobanking has gained immense traction across the globe as a vital resource in medical research, supporting different types of contemporary research, such as genomics and personalized medicine. Request for a free sample report: https://www.imarcgroup.com/biobanking-market/requestsample

4. Report Description and Highlights Report Description Global Biobanking Market Trends: The global biobanking market is primarily driven by the surging product adoption in understanding the pathogenic mechanisms, collecting high-quality and well-annotated human biospecimens, and identifying potential treatment targets for coronavirus disease (COVID-19). Moreover, there has been a rise in demand for biobanking to develop diagnostics that can accurately and quickly identify pathogens due to the rising prevalence of new infectious and chronic diseases. In line with this, the escalating demand for regenerative medicine and personalized treatment and the expanding geriatric population are positively influencing market growth. Additionally, continual innovations in bioenergy, environmental remediation, genomics, metagenomics, proteomics, disease biology, and allied fields are other major growth-inducing factors. Furthermore, the rising investment in virtual biobank network models by health agencies of numerous countries, as they offer electronic databases that help investigators locate biospecimens and data mining from multiple biobanks, is contributing to the market growth. Other factors, including the emerging trend of conserving cord blood stem cells of newborns, the rising need for cost-effective drug discovery and treatment, and advancements in biobanking, are also anticipated to propel the market growth.

5. Report Description Report Description and Highlights Market Summary: Breakup by Specimen Type: • • • • • Blood Products Solid Tissue Cell Lines Nucleic Acid Others Breakup by Biobank Type: • • Population-based Biobanks Disease-oriented Biobanks Market Breakup by Application: • • Therapeutics Research

6. Report Description Report Description and Highlights Breakup by End User: • • Academic Institutions Pharma and Biotech Companies Breakup by Region: • • • • • North America Europe Asia Pacific Middle East and Africa Latin America On account of the aforementioned factors, the market is anticipated to witness strong growth during 2023-2028.

7. Report Description Report Description and Highlights Competitive Landscape With Key player: • • • • • • • • • • • • Brooks Automation Inc. Bay Biosciences LLC Boca Biolistics Ctibiotech Cureline Inc. Firalis Greiner Bio-One International GmbH Hamilton Company Merck KGaA ProteoGenex Inc. Thermo Fisher Scientific Inc. VWR Corporation (Avantor Inc.) View Report TOC, Figures and Tables: https://www.imarcgroup.com/biobanking-market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com